DORAs such as Suvorexant and Lemborexant are used for insomnia as they cause sedation by blocking the arousing effects of endogenous orexins (Yoshimichi et al., 2001; Patel et al., 2015; Herring et al., 2019). The gene discussed is HCRT; the disease is insomnia.